These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31013501)

  • 21. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y; Wu T; Hu X; Wang T
    Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE; Baikova A; Maisonobe P; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):39-48. PubMed ID: 34932284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound Elastography to Assess Botulinum Toxin A Treatment for Post-stroke Spasticity: A Feasibility Study.
    Gao J; Rubin JM; Chen J; O'Dell M
    Ultrasound Med Biol; 2019 May; 45(5):1094-1102. PubMed ID: 30898386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional impact of different muscle localization techniques for Botulinum neurotoxin A injections in clinical routine management of post-stroke spasticity.
    Zeuner KE; Knutzen A; Kühl C; Möller B; Hellriegel H; Margraf NG; Deuschl G; Stolze H
    Brain Inj; 2017; 31(1):75-82. PubMed ID: 27880052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidimensional evaluation of changes in limb function following botulinum toxin injection in persons with stroke.
    Amatya B; Cofré Lizama LE; Elmalik A; Bastani A; Galea MP; Khan F
    NeuroRehabilitation; 2019; 45(1):67-78. PubMed ID: 31403954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasound-Guided BoNT-A (Botulinum Toxin A) Injection Into the Subscapularis for Hemiplegic Shoulder Pain: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Tan B; Jia L
    Stroke; 2021 Dec; 52(12):3759-3767. PubMed ID: 34470492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local muscle injection of botulinum toxin type a synergistically improves the beneficial effects of repetitive transcranial magnetic stimulation and intensive occupational therapy in post-stroke patients with spastic upper limb hemiparesis.
    Yamada N; Kakuda W; Kondo T; Mitani S; Shimizu M; Abo M
    Eur Neurol; 2014; 72(5-6):290-8. PubMed ID: 25323412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial.
    Do KH; Chun MH; Paik NJ; Park YG; Lee SU; Kim MW; Kim DK
    Clin Rehabil; 2017 Sep; 31(9):1179-1188. PubMed ID: 28118733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study.
    Picelli A; Vallies G; Chemello E; Gavras A; Castellazzi P; Meschieri A; Serina A; Gandolfi M; Baricich A; Santamato A; Cisari C; Smania N
    J Rehabil Med; 2017 May; 49(5):410-415. PubMed ID: 28471469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity.
    Ghroubi S; Alila S; Elleuch W; Ayed HB; Mhiri C; Elleuch MH
    Pan Afr Med J; 2020; 35():55. PubMed ID: 32523646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effects of botulinum toxin type A and repetitive transcranial magnetic stimulation with intensive motor training immediately after injection in a patient with chronic stroke: A case report.
    Hirakawa Y; Koyama S; Tanabe S; Takeda K; Ueda T; Motoya I; Sakurai H; Kanada Y; Kawamura N; Kawamura M; Nagata J; Kanno T
    J Hand Ther; 2019; 32(4):519-524. PubMed ID: 30025843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined therapy using botulinum toxin A and single-joint hybrid assistive limb for upper-limb disability due to spastic hemiplegia.
    Saita K; Morishita T; Hyakutake K; Fukuda H; Shiota E; Sankai Y; Inoue T
    J Neurol Sci; 2017 Feb; 373():182-187. PubMed ID: 28131185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke.
    Santamato A; Panza F; Intiso D; Baricich A; Picelli A; Smania N; Fortunato F; Seripa D; Fiore P; Ranieri M
    J Neurol Sci; 2017 Jul; 378():182-186. PubMed ID: 28566161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movement.
    Veverka T; Hluštík P; Hok P; Otruba P; Tüdös Z; Zapletalová J; Krobot A; Kaňovský P
    J Neurol Sci; 2014 Nov; 346(1-2):276-83. PubMed ID: 25255982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
    N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
    Turner-Stokes L; Jacinto J; Fheodoroff K; Brashear A; Maisonobe P; Lysandropoulos A; Ashford S;
    J Rehabil Med; 2021 Feb; 53(2):jrm00157. PubMed ID: 33616192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study.
    Baricich A; Picelli A; Carda S; Smania N; Cisari C; Santamato A; de Sire A; Invernizzi M
    Ann Phys Rehabil Med; 2019 Jul; 62(4):214-219. PubMed ID: 31228593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.